Key stats
About PARMAX PHARMA LIMITED
Sector
Headquarters
Rajkot
Founded
1994
Website
ISIN
INE240T01014
FIGI
BBG002HJM7F9
Parmax Pharma Ltd. engages in the manufacture of bulk drugs like ampicilin, amoxycillin, cephalexin, and nalidixic acid. The company also plans to extend its activities in formulation of tablets, capsules, ointments, & injectable. The company was founded on November 2, 1994 and is headquartered in Rajkot, India.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PARMAX is 49.75 INR — it has increased by 1.53% in the past 24 hours. Watch PARMAX PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange PARMAX PHARMA LIMITED stocks are traded under the ticker PARMAX.
PARMAX stock has risen by 5.20% compared to the previous week, the month change is a 8.27% rise, over the last year PARMAX PHARMA LIMITED has showed a 50.76% increase.
PARMAX reached its all-time high on Jun 18, 2021 with the price of 81.90 INR, and its all-time low was 12.50 INR and was reached on Mar 17, 2017. View more price dynamics on PARMAX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PARMAX stock is 6.38% volatile and has beta coefficient of 0.79. Track PARMAX PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is PARMAX PHARMA LIMITED there?
No, PARMAX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PARMAX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PARMAX PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PARMAX PHARMA LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PARMAX PHARMA LIMITED stock shows the strong buy signal. See more of PARMAX PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.